IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on July 30, 2019. The report serves to announce the Company's financial results for the second quarter ended June 30, 2019. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on the NASDAQ Capital Market under the symbol IRMD.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details has been issued and is attached as Exhibit 99.1.
Material Changes
The filing does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The filing explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 30, 2019) for actual Q2 2019 financial figures.
- Verify the specific revenue and net income numbers reported in the press release.
- Check for any updated full-year guidance provided in the press release.
- Confirm the status of the Company's emerging growth company election.